Bethesda Category IV carries a 25-40% risk of malignancy. FNAC cannot differentiate follicular adenoma from carcinoma. The standard management is diagnostic hemithyroidectomy.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.